This is a non-core endpoint: only basic statistics are computed.
Benign neoplasm: Choroid
CD2_BENIGN_CHOROID_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D31
- Name in latin
- Neoplasma benignum chorioideae
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Choroid
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm: Choroid
- Benign neoplasm of eye and adnexa
- Benign neoplasm of eye and adnexa
- Benign neoplasms
- Benign neoplasms
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 2095 | 1271 | 824 |
| Unadjusted period prevalence (%) | 0.41 | 0.43 | 0.36 |
| Median age at first event (years) | 65.29 | 63.15 | 68.58 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1836
- Matched controls
- 18361
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D31.3
ICD-10 Finland
Benign neoplasm: Choroid
4503599627370496.0
323.0
1828
15
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
13.7
300.2
562
574
XCK10
NOMESCO Finland
Photography of fundus of eye
8.0
235.4
614
1088
XCD10
NOMESCO Finland
Electrophysiological examination of eye
24.1
233.6
341
172
CK2L4
NOMESCO Finland
Wide-field/panoramic imaging of ocular fundus
194.9
217.3
223
13
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
6.7
167.2
479
915
115
Kela drug reimbursment
Breast cancer
+∞
113.7
108
*
Z01.0
ICD-10 Finland
Examination of eyes and vision
3.9
112.6
565
1876
C61
ICD-10 Finland
Malignant neoplasm of prostate
278.6
103.9
105
*
PJA12
NOMESCO Finland
Sentinel node biopsy
222.5
102.6
105
5
XCW99
NOMESCO Finland
Other investigative procedure of eye
4.4
101.3
426
1188
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
101.0
96
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
177.9
97.2
101
6
130
Kela drug reimbursment
Malignant tumour
+∞
86.1
82
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
79.8
76
*
C69.30
ICD-10 Finland
Malignant tumor of the chorioidea without histology
+∞
76.6
73
*
A04AA02
ATC
granisetron; systemic, transdermal
267.9
76.0
77
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
95.3
74.6
82
9
H02AB02
ATC
dexamethasone; systemic
14.7
67.7
116
84
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
671.5
66.4
65
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
57.6
55
*
L02BG04
ATC
letrozole; oral
24.6
54.9
78
33
116
Kela drug reimbursment
Prostate cancer
+∞
54.4
52
*
HAC20
NOMESCO Finland
Total mastectomy
146.9
54.1
57
*
CKE60
NOMESCO Finland
Brachytherapy of choroid and retina
+∞
51.3
49
*
CKE65
NOMESCO Finland
Removal of brachytherapeutic plate from eye
+∞
51.3
49
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
50.2
48
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
47.1
45
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
46.0
44
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
5.4
45.6
143
281
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
458.6
45.4
45
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
437.5
43.4
43
*
XCD20
NOMESCO Finland
Photoangiography of eye
8.9
42.7
93
109
CK2A4
NOMESCO Finland
Autofluorescence imaging of ocular fundus
57.0
42.6
50
9
L02BA01
ATC
tamoxifen; oral
94.3
41.9
46
5
XX3DW
NOMESCO Finland
Time consuming IT work
4.4
41.2
158
385
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
40.8
39
*
HAB40
NOMESCO Finland
Wedge excision of mammary gland
20.3
40.7
61
31
WF003
NOMESCO Finland
Adjuvant radiotherapy
90.1
39.9
44
5
L01BC06
ATC
capecitabine; oral
+∞
39.7
38
*
WF002
NOMESCO Finland
Radical radiotherapy
53.5
39.6
47
9
D31.2
ICD-10 Finland
Benign neoplasm: Retina
107.4
38.9
42
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
104.8
37.9
41
*
JN4BD
NOMESCO Finland
Extensive body CT
4.2
37.7
152
388
C69.32
ICD-10 Finland
Malignant tumor of the chorioidea melanoma
+∞
36.6
35
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
35.5
34
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
35.5
34
*
L03AA13
ATC
pegfilgrastim; parenteral
353.7
35.1
35
*
HA1AA
NOMESCO Finland
X-ray mammography
5.1
34.5
113
233
A03FA01
ATC
metoclopramide; systemic, rectal
2.6
33.4
280
1208
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.8
33.3
837
5743
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
61.1
31.1
36
6
C50
ICD-10 Finland
Malignant neoplasm of breast
318.0
30.9
31
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
29.2
28
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.9
28.5
499
2975
L02AE02
ATC
leuprorelin; implant, parenteral
14.5
28.5
48
34
Y77
ICPC
Malignant neoplasm prostate
+∞
28.2
27
*
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
28.2
27
*
JN4AD
NOMESCO Finland
Body CT examination
4.4
27.3
103
247
8520/3-C50.9
ICD-O-3
Lobular carcinoma, NOS, of breast, NOS
+∞
27.1
26
*
L02BB03
ATC
bicalutamide; oral
+∞
27.1
26
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
98.2
26.7
29
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
26.1
25
*
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
4.9
26.1
88
188
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
+∞
25.0
24
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
25.0
24
*
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
25.0
24
*
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
58.9
25.0
29
5
A04AA01
ATC
ondansetron; systemic, rectal
4.9
24.8
83
176
ZXA00
NOMESCO Finland
Right side
1.8
24.7
525
3320
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
24.0
23
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
24.0
23
*
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
+∞
24.0
23
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
24.0
23
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
23.0
22
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
5.5
22.9
69
130
WX140
NOMESCO Finland
Parabulbar anesthesy
3.3
22.9
122
392
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
232.7
22.7
23
*
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
121.5
22.6
24
*
WX408
NOMESCO Finland
General anesthesy, balanced
1.8
22.5
439
2684
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.6
22.3
168
673
Z96.1
ICD-10 Finland
Presence of intraocular lens
2.1
22.2
286
1496
ZXA10
NOMESCO Finland
Bilateral
1.9
22.1
377
2198
C50.81
ICD-10 Finland
Overall malignant tumor of the mammary gland, ductal tumor
+∞
21.9
21
*
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
21.9
21
*
HAB50
NOMESCO Finland
Partial excision of mammary gland with reconstructive operation
222.5
21.6
22
*
ZXA05
NOMESCO Finland
Left side
1.8
21.2
479
3063
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
20.9
20
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
20.9
20
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.6
20.8
768
5639
H43.8
ICD-10 Finland
Other disorders of vitreous body
2.3
20.2
202
940
NK6AN
NOMESCO Finland
Total body bone isotope imaging
19.0
20.0
30
16
D22.9
ICD-10 Finland
Melanocytic naevi, unspecified
3.8
19.9
87
240
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
19.8
19
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
19.8
19
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
19.8
19
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
74.3
19.7
22
*
D31.4
ICD-10 Finland
Benign neoplasm: Ciliary body
74.3
19.7
22
*
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
+∞
18.8
18
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
18.8
18
*
A04AD12
ATC
aprepitant; systemic
+∞
18.8
18
*
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
13.5
18.7
32
24
SPAT1153
SPAT
Removal of sutures
1.6
18.7
564
3897
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
191.8
18.6
19
*
L02BG03
ATC
anastrozole; oral
+∞
17.7
17
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
96.0
17.6
19
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
181.6
17.5
18
*
Z51.5
ICD-10 Finland
Palliative care
4.4
17.4
63
146
WX110
NOMESCO Finland
Local anesthesy
1.5
16.8
1127
9357
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.6
16.7
582
4149
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
+∞
16.7
16
*
HAE20
NOMESCO Finland
Reconstruction of areola and mamilla using graft or flap
+∞
16.7
16
*
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
+∞
16.7
16
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
16.7
16
*
C69.3
ICD-10 Finland
Malignant neoplasm: Choroid
+∞
16.7
16
*
HA4AT
NOMESCO Finland
Labeling mammary gland pathology with ultrasound guidance
10.8
16.5
31
29
R23.8
ICD-10 Finland
Other and unspecified skin changes
1.9
16.4
250
1387
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
4.6
16.0
55
122
WZC30
NOMESCO Finland
Teaching
2.1
16.0
181
893
S18
ICPC
Laceration/cut
1.5
15.9
702
5281
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
15.6
15
*
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
+∞
15.6
15
*
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
+∞
15.6
15
*
CH2S4
NOMESCO Finland
Photography of iris
161.3
15.5
16
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.9
15.4
96
345
H25.1
ICD-10 Finland
Senile nuclear cataract
1.6
15.2
478
3303
THW99
NOMESCO Finland
Other minor procedure in surgery of mammary gland
18.5
14.7
22
12
L03AA02
ATC
filgrastim; parenteral
21.2
14.7
21
10
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
14.6
14
*
L02BG06
ATC
exemestane; oral
+∞
14.6
14
*
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
+∞
14.6
14
*
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
80.7
14.6
16
*
L57.0
ICD-10 Finland
Actinic keratosis
2.2
14.6
146
681
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
2.7
14.3
100
384
XCH00
NOMESCO Finland
Eye pressure measurement
2.7
14.3
97
369
TPH04
NOMESCO Finland
Cathetrisation of vein
1.7
13.6
326
2087
X76
ICPC
Malignant neoplasm breast female
75.7
13.6
15
*
SPAT1262
SPAT
Handing over of treatment supplies
1.7
13.6
318
2021
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
13.6
13
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
+∞
13.6
13
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
13.6
13
*
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
13.6
13
*
WB401
NOMESCO Finland
Simple antibody therapy of primary tumour
+∞
13.6
13
*
C50.91
ICD-10 Finland
Malignant tumor in another specified localization in ductal mammary gland
+∞
13.6
13
*
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
13.6
13
*
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
+∞
13.6
13
*
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
34.3
13.5
17
5
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
34.3
13.5
17
5
TQW20
NOMESCO Finland
Tatoe
141.0
13.5
14
*
HA1DG
NOMESCO Finland
Very extensive MRI examination of mammary gland with high intensity magnet
141.0
13.5
14
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.5
13.4
535
3900
WX402
NOMESCO Finland
General anaesthesia
1.8
13.4
224
1284
CK9F4
NOMESCO Finland
Fluorescein angiography (FAG) of choroid and retina
7.3
13.2
31
43
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
2.8
13.1
86
321
H35.30
ICD-10 Finland
Kuhnt-Junius degeneration
2.4
13.0
114
496
B01AB10
ATC
tinzaparin; parenteral
2.6
12.9
95
377
H31.3
ICD-10 Finland
Choroidal haemorrhage and rupture
50.3
12.8
15
*
WX002
NOMESCO Finland
Sedation and analgesia
1.6
12.7
347
2298
HA1CG
NOMESCO Finland
Extensive MRI examination of mammary gland with high intensity magnet
15.5
12.6
20
13
S77
ICPC
Malignant neoplasm of skin
70.3
12.6
14
*
HAE10
NOMESCO Finland
Reconstruction of breast using graft or flap
70.3
12.6
14
*
N02BE01
ATC
paracetamol; systemic, rectal
1.6
12.5
1495
13553
CK2J4
NOMESCO Finland
Infrared imaging of ocular fundus
+∞
12.5
12
*
WF001
NOMESCO Finland
Preoperative radiotherapy
+∞
12.5
12
*
8720/3-C44.5
ICD-O-3
Malignant melanoma, NOS, of skin of trunk
+∞
12.5
12
*
8310/3-C64.9
ICD-O-3
Clear cell adenocarcinoma, NOS, of kidney, NOS
+∞
12.5
12
*
8720/3-C69.3
ICD-O-3
Malignant melanoma, NOS, of choroid
+∞
12.5
12
*
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
+∞
12.5
12
*
C44.11
ICD-10 Finland
Basocellular carcinoma of the skin of the eyelids including the corner of the eye
+∞
12.5
12
*
C50.22
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,lobular tumor
+∞
12.5
12
*
8500/2-C50.9
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS
+∞
12.5
12
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.1
12.4
138
674
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
5.8
12.2
34
60
WX302
NOMESCO Finland
Thoracal epidural anesthesy
3.3
12.0
59
182
H35.31
ICD-10 Finland
Senile macular degeneration (atrophic)(exudative)
2.6
11.6
87
350
WD205
NOMESCO Finland
Therapy of methastized malignancy with hormones
+∞
11.5
11
*
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
+∞
11.5
11
*
8500/3-C50.2
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast
+∞
11.5
11
*
8720/3-C69.9
ICD-O-3
Malignant melanoma, NOS, of eye, NOS
+∞
11.5
11
*
8720/3-C44.9
ICD-O-3
Malignant melanoma, NOS, of skin, NOS
+∞
11.5
11
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
120.7
11.4
12
*
UKC02
NOMESCO Finland
Cystoscopy
1.7
11.3
249
1551
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
15.1
11.3
18
12
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
3.8
11.2
46
123
D31.0
ICD-10 Finland
Benign neoplasm: Conjunctiva
6.4
11.1
28
44
H31.9
ICD-10 Finland
Disorder of choroid, unspecified
43.6
10.9
13
*
H04.10
ICD-10 Finland
Dry eye syndrome
1.9
10.8
175
988
H35.38
ICD-10 Finland
Preretinal fibrosis of the macula
2.6
10.6
78
311
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
60.3
10.6
12
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
60.3
10.6
12
*
A98
ICPC
Health maint/preventive medicine
1.9
10.5
1724
16378
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
110.6
10.4
11
*
C43.52
ICD-10 Finland
Malignant melanoma on the torso: 'superficial spreading' type
110.6
10.4
11
*
C50.11
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,ductal tumor
+∞
10.4
10
*
C18.71
ICD-10 Finland
Malignant tumor of the sigmoid invasive carcinoma
+∞
10.4
10
*
KEC00
NOMESCO Finland
Retropubic radical prostatectomy
+∞
10.4
10
*
I97.2
ICD-10 Finland
Postmastectomy lymphoedema syndrome
+∞
10.4
10
*
J01DB01
ATC
cefalexin; oral
1.4
10.3
1374
12377
H40.0
ICD-10 Finland
Glaucoma suspect
1.9
10.2
150
817
ZXC96
NOMESCO Finland
Robot assisted procedure
7.5
10.2
23
31
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
2.3
10.2
96
437
CKD05
NOMESCO Finland
Puncture of vitreous body with injection of medication
2.3
10.2
93
417
TPH07
NOMESCO Finland
Cathetrisation of artery
1.9
10.1
148
807
WX100
NOMESCO Finland
Conjunctival surface anesthesia
1.7
10.1
219
1356
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.8
10.1
189
1122
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.6
10.0
280
1856
JN4CD
NOMESCO Finland
Very extensive body CT
4.0
10.0
39
100
A79
ICPC
Malignancy NOS
40.3
10.0
12
*
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.5
9.9
419
3061
KCD02
NOMESCO Finland
Transurethral resection of bladder
7.7
9.9
22
29
XKD00
NOMESCO Finland
Uroflowmetry
1.7
9.8
224
1409
CJB10
NOMESCO Finland
Laser discission of secondary cataract
1.8
9.6
158
898
KCD05
NOMESCO Finland
Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)
100.5
9.4
10
*
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
+∞
9.4
9
*
C50.51
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor
+∞
9.4
9
*
C69.39
ICD-10 Finland
Malignant tumor in chorioidea other or unspecified histology
+∞
9.4
9
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
9.4
9
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
9.4
9
*
8140/3-C18.7
ICD-O-3
Adenocarcinoma, NOS, of sigmoid colon
+∞
9.4
9
*
L01CA04
ATC
vinorelbine; systemic
+∞
9.4
9
*
Z85.3
ICD-10 Finland
Personal history of malignant neoplasm of breast
+∞
9.4
9
*
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
+∞
9.4
9
*
C34.82
ICD-10 Finland
Malignant overall tumor of bronchial and pulmonary adenocarcinoma
+∞
9.4
9
*
HAB99
NOMESCO Finland
Other partial excision of mammary gland
5.4
9.4
27
51
UJF32
NOMESCO Finland
Coloscopy
1.5
9.3
410
3014
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.4
9.1
595
4708
XJH00
NOMESCO Finland
Transanal ultrasonography
2.3
9.0
85
387
A06AC01
ATC
ispaghula (psylla seeds); oral
1.5
9.0
405
2986
T90
ICPC
Diabetes non-insulin dependent
1.5
9.0
396
2912
ZXC50
NOMESCO Finland
Cryotherapy
3.5
9.0
40
116
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.0
8.9
110
561
WX704
NOMESCO Finland
Intubation
2.0
8.9
112
577
B01AB05
ATC
enoxaparin; parenteral
1.4
8.8
453
3429
R44
ICPC
Respiratory, Preventive immunization/medic
3.3
8.8
42
129
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
50.2
8.7
10
*
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
2.3
8.6
73
318
CA1ME
NOMESCO Finland
Ultrasound oculometry
5.4
8.4
24
45
M01AE01
ATC
ibuprofen; systemic, rectal
1.4
8.4
1504
13933
XX1XN
NOMESCO Finland
Other isotope examination
90.4
8.4
9
*
352
Kela drug reimbursment
Abiraterone and enzalutamide
+∞
8.3
8
*
C43.72
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip: 'superficial spreading' type
+∞
8.3
8
*
C50.89
ICD-10 Finland
Overall malignant tumor of the mammary gland, other or undeterminated histology
+∞
8.3
8
*
YG1CD
NOMESCO Finland
Very extensive CT examination of thorax for dose design of radiotherapy
+∞
8.3
8
*
1CD02
NOMESCO Finland
NA
+∞
8.3
8
*
C50.20
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,no histological veryfication
+∞
8.3
8
*
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
+∞
8.3
8
*
8380/3-C54.1
ICD-O-3
Endometrioid adenocarcinoma, NOS, of endometrium
+∞
8.3
8
*
8090/3-C44.4
ICD-O-3
Basal cell carcinoma, NOS, of skin of scalp and neck
+∞
8.3
8
*
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
8.3
8
*
C50.29
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland, other or undeterminated histology
+∞
8.3
8
*
C50.82
ICD-10 Finland
Overall malignant tumor of the mammary gland, lobular tumor
+∞
8.3
8
*
163
Kela drug reimbursment
Abiraterone and enzalutamide
+∞
8.3
8
*
H53.1
ICD-10 Finland
Subjective visual disturbances
2.0
8.3
109
572
H35.39
ICD-10 Finland
Degeneration of macula and posterior pole
2.5
8.2
61
248
H26.4
ICD-10 Finland
After-cataract
1.7
8.1
169
1037
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
17.2
8.1
12
7
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
3.6
8.1
34
95
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.7
8.0
181
1132
ZZF00
NOMESCO Finland
Graft of adipose tissue
22.1
8.0
11
5
CD2S4
NOMESCO Finland
Photography of eye
6.3
8.0
20
32
R74.8
ICD-10 Finland
Abnormal levels of other serum enzymes
2.7
8.0
53
203
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
2.7
8.0
52
197
SPAT1263
SPAT
Sampling
1.3
7.9
697
5755
H3600, E113
ICD-10 Finland
NA
3.8
7.8
31
82
JN6AD
NOMESCO Finland
CT of torso and neck
9.4
7.8
15
16
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.3
7.8
690
5704
ZX112
NOMESCO Finland
Subcutaneous
5.0
7.7
23
46
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
15.1
7.7
12
8
AA1BD
NOMESCO Finland
Extensive CT of head and brain
3.3
7.7
36
110
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
4.4
7.6
26
60
ZZR10
NOMESCO Finland
Flap of skin and muscle
18.4
7.6
11
6
N02AA05
ATC
oxycodone; systemic
1.7
7.5
170
1067
A02BC02
ATC
pantoprazole; systemic
1.3
7.5
1050
9258
KE1BE
NOMESCO Finland
Rectal ultrasound examinaiton of prostata
1.9
7.4
107
583
HAC15
NOMESCO Finland
Subcutaneous mastectomy with excision of mamilla
80.4
7.4
8
*
CF2S4
NOMESCO Finland
Photography of conjunctiva
13.4
7.4
12
9
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
3.2
7.4
37
119
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
5.6
7.4
20
36
CKC12
NOMESCO Finland
Photocoagulation of retina
2.1
7.3
79
386
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.3
7.3
618
5059
C34.32
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma
+∞
7.3
7
*
HA013
NOMESCO Finland
Radiotherapy after total ablation of mammary gland
+∞
7.3
7
*
C18.01
ICD-10 Finland
Malignant tumor of the caecum invasive carcinoma
+∞
7.3
7
*
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
+∞
7.3
7
*
8720/3-C44.7
ICD-O-3
Malignant melanoma, NOS, of skin of lower limb and hip
+∞
7.3
7
*
C50.10
ICD-10 Finland
Malignant tumor of the central part of the mammary gland, no histological veryfication
+∞
7.3
7
*
SPAT1325
SPAT
Vaccination
1.3
7.1
594
4843
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
3.2
7.1
35
111
J01MA02
ATC
ciprofloxacin; systemic
1.3
7.1
595
4857
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
2.8
7.1
42
150
S82
ICPC
Naevus/mole
1.6
7.1
180
1166
WX720
NOMESCO Finland
Own respiration
2.3
7.1
63
283
N40
ICD-10 Finland
Hyperplasia of prostate
1.4
7.1
303
2205
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.3
7.0
876
7567
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
1.8
7.0
105
583
TPX10
NOMESCO Finland
Implantation of vascular injection port
3.3
6.9
32
97
H25.0
ICD-10 Finland
Senile incipient cataract
1.8
6.9
108
607
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
8.3
6.8
14
17
E0000UV
ATC
NA
1.3
6.8
589
4828
8130/2-C67.9
ICD-O-3
Papillary urothelial carcinoma, non-invasive of bladder, NOS
40.2
6.8
8
*
NK6AQ
NOMESCO Finland
Whole body bone SPET with low dose CT
40.2
6.8
8
*
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.5
6.7
243
1709
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
3.2
6.6
32
101
H53.9
ICD-10 Finland
Visual disturbance, unspecified
2.4
6.6
51
215
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
8.7
6.5
13
15
R50.9
ICD-10 Finland
Fever, unspecified
1.6
6.5
177
1167
CA1AE
NOMESCO Finland
Eye and orbita ultrasound examination
6.9
6.5
15
22
103
Kela drug reimbursment
Diabetes, insulin-treated
1.4
6.5
432
3398
C18.70
ICD-10 Finland
Malignant tumor of the sigmoid without histology
70.1
6.4
7
*
C44.71
ICD-10 Finland
Basocellular carcinoma of the skin of the lower extremity including the hip
70.1
6.4
7
*
UDC00
NOMESCO Finland
Ear microscopy
1.8
6.4
111
644
H35.0
ICD-10 Finland
Background retinopathy and retinal vascular changes
6.0
6.3
16
27
H35.7
ICD-10 Finland
Separation of retinal layers
3.8
6.3
24
63
C20.99
ICD-10 Finland
Malignant tumor of the rectum other or unspecified histology
+∞
6.3
6
*
C50.31
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor
+∞
6.3
6
*
C69.02
ICD-10 Finland
Malignant tumor in conjunctival melanoma
+∞
6.3
6
*
L01BC59
ATC
trifluridine, combinations; systemic
+∞
6.3
6
*
8090/3-C44.1
ICD-O-3
Basal cell carcinoma, NOS, of eyelid
+∞
6.3
6
*
C50.00
ICD-10 Finland
Malignant tumor of nipple and areola, no histological veryfication
+∞
6.3
6
*
C82.1
ICD-10 Finland
Follicular lymphoma grade II
+∞
6.3
6
*
8140/3-C34.9
ICD-O-3
Adenocarcinoma, NOS, of lung, NOS
+∞
6.3
6
*
8097/3-C44.9
ICD-O-3
Basal cell carcinoma, nodular of skin, NOS
+∞
6.3
6
*
1906B
ICD-9 Finland
Malignant neoplasm of eye, Choroid[MELANOMA CHORIOIDEAE]
+∞
6.3
6
*
PJ5AQ
NOMESCO Finland
Sentinell lymphnode SPECT with low dose CT
+∞
6.3
6
*
WB402
NOMESCO Finland
Demanding antibody therapy of primary tumour
+∞
6.3
6
*
C34.3
ICD-10 Finland
Malignant neoplasm: Lower lobe, bronchus or lung
+∞
6.3
6
*
L02BB04
ATC
enzalutamide; oral
+∞
6.3
6
*
WB223
NOMESCO Finland
Demanding adjuvant hormone therapy of malignancy
+∞
6.3
6
*
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
+∞
6.3
6
*
C20
ICD-10 Finland
Malignant neoplasm of rectum
+∞
6.3
6
*
L02BA03
ATC
fulvestrant; parenteral
+∞
6.3
6
*
K62.7
ICD-10 Finland
Radiation proctitis
+∞
6.3
6
*
C50.4
ICD-10 Finland
Malignant neoplasm: Upper-outer quadrant of breast
+∞
6.3
6
*
128
Kela drug reimbursment
Cancers of female genital organs
+∞
6.3
6
*
C67.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of bladder
+∞
6.3
6
*
C43.50
ICD-10 Finland
Malignant melanoma of the torso without histology
+∞
6.3
6
*
R01AD09
ATC
mometasone; nasal
1.3
6.2
680
5736
J02AC01
ATC
fluconazole; systemic
1.3
6.2
596
4942
C44.61
ICD-10 Finland
Basocellular carcinoma of the skin of the upper extremity including the shoulder
26.8
6.2
8
*
C44.21
ICD-10 Finland
Basocellular carcinoma of the skin of the outer ear and the outer ear canal
26.8
6.2
8
*
H31.8
ICD-10 Finland
Other specified disorders of choroid
26.8
6.2
8
*
JG1CG
NOMESCO Finland
Extensive MRI of rectum
26.8
6.2
8
*
SAA03
NOMESCO Finland
Extended examination of mouth
1.3
6.2
564
4642
Z31.5
ICD-10 Finland
Genetic counselling
2.4
6.2
48
203
F38
ICPC
Eye, Other laboratory test NEC
6.3
6.2
15
24
R31
ICD-10 Finland
Unspecified haematuria
1.7
6.2
134
831
TCG40
NOMESCO Finland
Measurement of higher-grade errors of refraction
5.3
6.1
17
32
XCK00
NOMESCO Finland
Perimetry
1.7
6.1
119
714
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
2.6
6.1
40
154
C05AA08
ATC
fluocortolone; rectal, topical
1.5
6.0
220
1547
A02BC05
ATC
esomeprazole; systemic
1.3
6.0
652
5488
ZZR00
NOMESCO Finland
Flap of skin
5.2
6.0
17
33
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
236
932
2.73
40.86
4.7
1.4
19.1
3.5
ug/l
1.16
199
689
1050
7716
1.72
32.04
6.5
5.0
1.2
1.2
mmol/l
0.76
945
6805
1092
8135
1.72
31.50
7.0
3.8
11.0
11.6
umol/l
1.21
1038
7593
1199
9174
1.72
31.24
9.3
6.4
4.0
4.3
e9/l
3.05
1071
7872
1136
8575
1.71
31.03
7.1
5.5
1.2
1.2
mmol/l
0.12
918
7196
1558
13014
1.77
27.72
9.0
5.4
77.0
76.4
u/l
0.25
1455
12006
25
23
10.99
23.35
3.5
1.1
36.2
20.0
u/ml
1.04
25
23
929
7051
1.57
21.86
5.3
3.7
35.5
35.7
g/l
0.62
854
6457
1971
18184
2.42
20.95
19.6
15.3
139.8
139.8
mmol/l
0.22
1928
17668
1972
18239
2.38
20.09
19.7
15.4
4.0
4.0
mmol/l
0.29
1926
17694
1354
11303
1.56
20.03
5.1
4.5
38.7
1962.2
e6/l
3.08
13
163
288
1641
1.88
19.76
5.1
3.0
228.0
237.7
u/l
0.76
272
1529
1991
18539
2.49
19.13
12.9
9.2
25.0
25.0
u/l
0.04
1914
17712
1887
17233
1.96
18.81
16.6
12.7
21.7
22.9
mg/l
0.91
1497
13367
1983
18501
2.34
17.76
20.1
14.8
78.9
77.4
umol/l
1.05
1983
18495
2033
19195
3.00
17.60
25.3
18.9
248.3
249.8
e9/l
0.47
1988
18593
2033
19202
2.98
17.45
25.2
18.9
4.5
4.5
e12/l
1.71
1979
18521
2033
19203
2.98
17.43
25.3
18.9
6.6
6.7
e9/l
0.50
1982
18518
2033
19205
2.98
17.38
25.4
19.0
134.5
135.5
g/l
2.81
2004
18843
927
7274
1.49
17.33
4.2
3.6
—
—
—
0
0
1827
16694
1.74
15.75
6.9
6.2
40.8
40.2
mmol/mol
1.80
1666
15374
774
5991
1.46
14.82
3.6
3.1
7.0
7.2
mmol/l
0.66
625
4999
30
59
5.14
14.59
3.8
1.1
55.1
78.1
u/ml
—
9
17
721
5549
1.46
14.03
3.8
2.0
2.4
2.4
mmol/l
0.09
601
4607
19
24
7.98
14.03
1.2
1.1
—
—
—
0
0
777
6118
1.43
13.16
4.5
4.0
10.3
8.0
mg/mmol
0.55
469
3774
1193
10132
1.41
13.09
5.2
4.2
6.8
6.8
mmol/l
0.12
1136
9418
356
2412
1.57
12.61
4.0
2.5
0.8
0.8
mmol/l
0.15
322
2204
1691
15373
1.52
12.47
17.7
14.2
39.7
39.4
%
0.57
1080
10263
1867
17411
1.66
11.78
5.4
4.9
6.0
6.0
mmol/l
0.18
1679
15743
1772
16324
1.55
11.76
5.5
4.8
3.3
2.0
mu/l
0.44
1591
14793
1910
17950
1.73
11.31
5.8
5.3
2.6
2.7
mmol/l
3.76
1728
16427
486
3601
1.46
11.09
1.3
1.3
1.0
1.6
u/ml
1.75
119
946
382
2705
1.50
10.94
1.8
1.7
—
—
—
0
0
939
7825
1.36
10.66
2.1
2.0
98.9
95.4
pmol/l
1.11
433
3901
654
5166
1.39
10.27
3.9
2.6
30.3
33.7
u/l
1.13
626
4877
1470
13186
1.38
10.18
4.6
4.2
12.3
12.2
mm/h
0.07
1353
12138
70
305
2.34
9.85
1.5
1.4
—
—
—
0
0
630
4988
1.38
9.63
1.8
1.6
1.3
1.4
mmol/l
0.49
530
4161
1512
13675
1.38
9.60
4.5
4.0
14.9
14.9
pmol/l
0.12
1346
12325
888
7429
1.34
9.44
2.5
2.2
80.3
79.0
nmol/l
0.59
771
6500
1545
14057
1.38
9.20
20.1
15.4
13.7
13.7
%
0.82
1511
13691
173
1063
1.68
9.02
8.3
6.9
24.4
24.6
mmol/l
0.43
162
981
1865
17591
1.55
8.84
5.1
4.7
4.6
4.6
mmol/l
2.53
1701
16192
1850
17446
1.52
8.49
5.1
4.7
1.5
1.5
mmol/l
0.35
1678
15949
197
1278
1.60
8.29
2.4
2.0
0.2
0.2
g/l
0.49
183
1160
657
5349
1.33
8.10
2.9
2.3
57.5
58.4
u/l
0.15
603
4889
176
1119
1.63
8.05
2.8
2.2
10.3
10.8
g/l
0.77
162
1017
643
5233
1.33
7.91
5.9
3.9
2.5
2.7
ug/l
0.10
564
4677
70
336
2.12
7.86
3.8
1.9
126.6
94.4
u/ml
0.18
58
269
262
1834
1.49
7.81
6.5
6.7
1.2
1.3
mmol/l
0.25
200
1416
1209
10730
1.30
7.79
3.5
3.0
46.6
46.3
u/l
0.04
1113
9835
51
216
2.40
7.71
1.6
1.4
—
—
—
0
0
223
1513
1.53
7.71
7.1
7.2
118.1
122.2
g/l
2.30
213
1455
67
319
2.14
7.69
1.5
1.4
—
—
—
0
0
294
2122
1.45
7.48
6.3
5.0
1.1
1.0
mmol/l
0.58
261
1947
272
1941
1.46
7.34
1.8
2.1
117.8
134.0
ug/g
0.25
208
1503
979
8493
1.29
7.34
5.2
5.0
0.0
0.0
estimate
0.50
197
1480
1096
9648
1.29
7.31
2.7
2.6
—
—
—
0
0
239
1667
1.49
7.24
3.7
3.1
195.5
204.3
ng/l
0.10
217
1534
210
1426
1.53
7.23
3.5
3.5
92.6
88.6
ng/l
0.21
176
1221
260
1846
1.47
7.20
6.6
6.6
5.0
5.1
kpa
0.76
248
1757
260
1846
1.47
7.20
6.6
6.6
12.0
11.7
kpa
0.42
249
1756
38
145
2.65
7.14
1.8
1.3
—
—
—
0
0
973
8458
1.28
7.09
4.1
3.7
0.0
0.0
estimate
0.00
189
1467
35
129
2.74
7.03
1.8
1.3
—
—
—
0
0
24
71
3.41
6.97
2.1
1.6
553.6
845.8
e6/l
—
9
33
985
8591
1.28
6.93
4.2
3.8
0.0
0.0
estimate
1.08
190
1443
170
1114
1.57
6.87
1.7
1.6
—
—
—
0
0
53
245
2.19
6.59
1.4
1.5
—
—
—
0
0
814
6973
1.27
6.50
4.1
3.8
29.3
60.9
ng/l
1.93
553
4916
462
3673
1.33
6.49
2.0
1.8
1.0
1.2
mg/l
1.55
352
2803
1738
16368
1.36
6.49
15.8
11.7
77.2
77.3
ml/min/173m2
0.03
1444
13118
131
820
1.64
6.41
2.5
2.1
12.9
14.2
nmol/l
0.91
116
712
519
4208
1.31
6.33
5.3
3.8
22.6
24.1
%
1.47
238
2005
236
1688
1.45
6.28
4.1
3.2
—
—
—
0
0
236
1695
1.44
6.15
3.6
2.2
7.8
7.8
umol/l
0.03
207
1461
53
254
2.11
6.05
1.2
1.3
—
—
—
0
0
42
183
2.32
6.03
2.5
3.4
1.5
1.5
%
0.00
34
127
556
4576
1.29
6.02
4.8
4.1
0.0
0.0
estimate
0.88
190
1451
650
5484
1.27
5.72
3.2
3.1
1758.3
1401.7
ng/l
0.55
545
4679
198
1405
1.45
5.51
3.1
1.5
66.1
67.0
g/l
1.05
175
1257
109
679
1.64
5.48
2.0
1.7
—
—
—
0
0
815
7089
1.24
5.44
2.9
2.8
122.6
122.1
ug/l
0.02
743
6495
21
68
3.11
5.34
2.2
2.0
14.0
12.2
%
0.21
12
27
440
3561
1.30
5.34
4.1
3.8
458.8
422.9
ng/l
0.06
351
2870
543
4523
1.27
5.24
3.4
2.9
0.3
0.5
e6/l
1.88
408
3392
1773
16870
1.33
5.23
4.5
4.2
1.3
1.3
mmol/l
0.66
1602
15281
35
151
2.34
5.18
1.1
1.2
63.7
55.8
u/l
0.34
27
104
41
191
2.17
5.08
3.9
1.8
2029.4
51.2
u/ml
0.50
35
172
192
1376
1.44
5.08
4.7
2.9
1.2
1.2
mmol/l
0.23
161
1155
16
45
3.58
5.04
2.2
1.1
—
—
—
0
0
16
45
3.58
5.04
2.2
1.2
—
—
—
0
0
16
45
3.58
5.04
2.2
1.1
—
—
—
0
0
112
718
1.59
5.03
2.7
1.9
38.8
39.4
u/l
0.11
97
626
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
80
470
1.73
5.02
2.5
3.4
0.4
0.4
u/ml
0.05
51
284
672
5767
1.24
4.96
2.0
2.1
154.9
225.3
u/l
2.00
624
5389
101
635
1.62
4.92
1.7
1.6
—
—
—
0
0
441
3616
1.28
4.79
2.5
2.1
—
—
—
0
0
9
10
9.03
4.78
1.0
1.1
—
—
—
0
0
751
6549
1.23
4.73
4.3
3.9
—
—
—
0
0
83
503
1.68
4.68
3.3
3.0
—
—
—
0
0
142
978
1.48
4.63
4.1
3.0
4.4
4.5
pmol/l
0.97
126
849
22
81
2.73
4.51
1.0
1.3
—
—
—
0
0
78
471
1.68
4.47
1.4
1.4
301.2
296.4
ug/g
0.07
44
276
325
2584
1.31
4.46
2.5
2.5
12.5
13.1
umol/l
0.71
295
2369
247
1888
1.35
4.46
1.7
1.7
—
—
—
0
0
424
3490
1.27
4.44
2.9
2.4
5.8
5.8
e6/l
0.01
375
3024
246
1890
1.34
4.30
1.7
1.7
—
—
—
0
0
323
2579
1.30
4.30
2.0
2.0
29.5
29.8
s
0.50
312
2482
76
461
1.67
4.30
1.4
1.3
30.1
31.7
iu/l
0.17
70
399
64
371
1.75
4.26
1.5
1.3
—
—
—
0
0
48
255
1.90
4.22
1.2
1.3
—
—
—
0
0
37
179
2.09
4.22
1.3
1.4
—
—
—
0
0
7
7
10.03
4.01
1.0
1.1
8.3
7.6
mmol/l
—
7
7
52
289
1.82
4.00
4.3
3.4
55.8
57.5
%
0.46
52
289
44
232
1.92
3.98
1.1
1.1
0.1
1.6
u/ml
1.67
22
90
48
261
1.86
3.96
1.6
1.3
10.6
10.4
u/l
0.03
40
211
31
144
2.17
3.93
2.6
1.6
603.8
962.0
u/ml
0.13
31
138
379
3132
1.26
3.81
3.1
2.2
2.5
2.4
mmol/l
0.40
317
2699
18
67
2.70
3.66
2.3
2.5
2284.3
992.5
u/ml
0.47
18
67
69
430
1.63
3.57
2.5
2.0
11.7
11.7
mg/l
0.01
62
393
38
199
1.93
3.54
1.7
1.2
—
—
—
0
0
183
1387
1.35
3.53
2.6
2.1
35.1
38.4
u/l
0.34
162
1169
37
193
1.93
3.49
1.6
1.2
—
—
—
0
0
38
201
1.91
3.44
1.7
1.2
—
—
—
0
0
37
194
1.92
3.44
1.6
1.2
—
—
—
0
0
27
126
2.16
3.42
2.3
2.9
68.4
55.4
%
2.35
19
74
38
202
1.90
3.40
1.7
1.2
—
—
—
0
0
17
64
2.67
3.39
2.4
2.0
—
—
—
0
0
304
2481
1.26
3.39
1.4
1.4
—
—
—
0
0
37
195
1.91
3.39
1.6
1.2
—
—
—
0
0
431
3656
1.23
3.39
1.8
1.8
1252.6
1170.2
nmol/l
1.02
319
2744
308
2522
1.26
3.34
3.2
2.7
1.8
2.9
e6/l
2.87
159
1358
514
4450
1.21
3.28
1.5
1.5
22.3
21.1
nmol/l
0.68
428
3727
350
2919
1.24
3.23
3.7
2.7
0.7
0.7
ug/l
0.31
239
1976
17
66
2.59
3.21
1.1
1.1
5893.5
145.8
ng/l
—
6
12
76
499
1.54
3.19
3.5
1.4
3.5
1.5
ratio
—
8
49
62
388
1.62
3.19
3.0
3.0
1.7
1.6
mg/l
0.35
54
345
103
722
1.45
3.16
4.0
5.1
1.7
1.6
%
0.79
94
677
39
215
1.83
3.14
1.2
1.3
—
—
—
0
0
180
1386
1.33
3.14
9.7
7.0
10.8
10.3
mmol/l
0.38
170
1315
16
61
2.64
3.13
2.2
1.2
—
—
—
0
0
16
61
2.64
3.13
2.2
1.2
—
—
—
0
0
16
61
2.64
3.13
2.2
1.2
—
—
—
0
0
16
61
2.64
3.13
2.2
1.2
—
—
—
0
0
21
92
2.30
3.10
1.7
1.4
4.7
7.8
u/l
0.43
15
40
268
2179
1.26
3.09
2.5
2.6
22.8
22.7
%
0.02
206
1828
10
29
3.46
3.04
1.0
1.1
—
—
—
0
0
25
119
2.11
3.04
1.8
1.2
—
—
—
0
0
25
119
2.11
3.04
1.8
1.2
—
—
—
0
0
25
119
2.11
3.04
1.8
1.2
—
—
—
0
0
289
2377
1.25
3.02
5.1
4.8
33.4
32.9
%
0.26
191
1549
43
248
1.75
3.00
1.2
1.3
—
—
—
0
0
39
220
1.79
2.94
8.1
5.3
1513.7
419.9
iu/ml
—
7
30
286
2362
1.24
2.89
2.5
2.5
2.3
2.3
g/l
0.79
257
2181
35
192
1.84
2.89
1.3
1.3
—
—
—
0
0
6
9
6.68
2.87
1.2
2.6
—
—
—
0
0
68
448
1.54
2.85
1.1
1.1
4.2
6.5
u/ml
—
7
41
329
2765
1.23
2.82
3.0
2.6
1.0
1.3
e6/l
1.03
182
1594
76
518
1.48
2.73
3.5
1.4
38.1
44.9
mg/l
0.21
58
420
27
139
1.95
2.70
1.4
1.5
—
—
—
0
0
35
197
1.79
2.68
1.0
1.1
1.5
1.5
g/l
0.03
27
170
76
520
1.48
2.68
3.5
1.4
50.8
44.0
mg/l
0.27
57
423
135
1024
1.34
2.65
3.5
3.5
1.6
1.8
mmol/l
0.29
89
754
189
1503
1.28
2.64
2.6
1.8
340.0
362.3
nmol/l
0.98
167
1355
61
400
1.54
2.63
1.5
1.2
3.9
3.9
mmol/l
0.19
55
367
20
396
0.50
2.54
4.0
3.0
7.4
7.6
mmol/l
0.09
20
381
88
627
1.42
2.53
1.8
1.7
2.7
1.6
ug/l
0.33
72
540
13
50
2.61
2.53
1.0
1.1
—
—
—
0
0
23
115
2.01
2.51
1.2
1.4
6.8
7.2
mmol/l
0.25
23
105
83
587
1.43
2.49
2.1
1.4
1.5
0.4
g/l
1.26
67
501
22
417
0.52
2.45
3.8
2.9
1.4
1.6
mmol/l
1.68
22
402
69
473
1.47
2.44
1.2
1.2
—
—
—
0
0
463
4071
1.18
2.43
1.7
1.7
47283034.4
35896332.7
pmol/l
0.13
368
3343
21
103
2.05
2.41
1.4
1.4
—
—
—
0
0
283
2381
1.22
2.41
1.4
1.4
—
—
—
0
0
10
34
2.95
2.41
1.3
1.0
—
—
—
0
0
10
34
2.95
2.41
2.6
1.7
—
—
—
0
0
139
1075
1.31
2.41
3.5
3.6
5.1
5.2
kpa
0.17
122
994
174
1389
1.28
2.38
2.6
2.4
63.1
64.8
ml/min/173m2
0.24
77
562
73
509
1.45
2.37
1.7
1.7
—
—
—
0
0
516
4595
1.16
2.30
2.9
2.4
1945.2
6311.4
umol/l
2.85
427
3925
52
342
1.53
2.25
2.3
2.3
15.5
16.3
%
0.63
30
179
30
171
1.77
2.25
1.1
1.1
—
—
—
0
0
32
186
1.73
2.25
1.3
1.3
—
—
—
0
0
15
66
2.28
2.24
1.1
1.1
—
—
—
0
0
44
279
1.59
2.23
1.8
1.4
84.7
81.8
pmol/l
0.04
44
269
90
663
1.37
2.18
1.6
1.4
2.9
3.0
g/l
0.63
62
508
15
67
2.25
2.17
1.1
1.0
90.4
92.6
%
—
10
54
45
290
1.56
2.14
1.4
1.5
—
—
—
0
0
48
315
1.54
2.12
1.3
1.6
—
—
—
0
0
5
10
5.01
2.07
1.8
1.4
—
—
—
0
0
5
10
5.01
2.07
1.0
1.0
—
—
—
0
0
28
161
1.75
2.06
1.5
1.5
—
—
—
0
0
90
670
1.36
2.05
3.9
3.9
24.7
24.8
mmol/l
0.11
75
618
490
4384
1.15
2.04
2.4
2.2
2.6
2.9
mg/l
2.46
409
3728
17
83
2.06
2.01
1.4
1.3
12.8
14.6
u/l
0.65
17
78
7
21
3.34
1.96
1.0
1.0
—
—
—
0
0
281
2414
1.19
1.94
7.9
6.5
—
—
—
0
0
5
11
4.55
1.94
1.8
1.3
—
—
—
0
0
88
661
1.35
1.92
1.6
1.4
9.7
10.5
g/l
0.91
65
548
15
72
2.09
1.86
1.4
1.4
—
—
—
0
0
15
72
2.09
1.86
1.4
1.4
—
—
—
0
0
234
1987
1.20
1.85
7.5
5.7
104.5
104.1
mmol/l
0.59
228
1936
24
137
1.76
1.83
1.6
1.6
36603.9
82091.8
e6/l
0.43
12
81
93
711
1.32
1.81
1.6
1.4
—
—
—
0
0
93
711
1.32
1.81
1.6
1.4
7.0
7.5
g/l
1.88
64
518
93
711
1.32
1.81
1.6
1.4
3.7
3.9
g/l
0.56
59
498
26
153
1.71
1.80
1.5
1.5
1088.6
1808.0
e6/l
1.32
19
110
25
146
1.72
1.77
1.0
1.1
0.4
3.8
u/ml
1.97
14
58
15
74
2.03
1.75
9.3
4.1
—
—
—
0
0
6
18
3.34
1.74
1.0
1.2
—
—
—
0
0
20
110
1.83
1.73
1.6
2.0
14.5
18.4
nmol/l
1.12
20
97
31
194
1.61
1.72
4.5
6.2
6.9
7.5
mmol/l
0.60
23
155
5
13
3.85
1.71
1.2
1.0
—
—
—
0
0
5
13
3.85
1.71
1.2
1.2
—
—
—
0
0
17
89
1.92
1.70
1.3
1.2
—
—
—
0
0
226
1930
1.19
1.69
2.1
2.2
1.8
1.8
%
0.21
193
1683
57
408
1.41
1.69
1.4
1.3
—
—
—
0
0
38
252
1.52
1.66
1.8
1.8
2.0
1.8
mmol/l
0.60
38
246
26
157
1.66
1.66
1.2
1.1
—
—
—
0
0
17
90
1.90
1.65
1.3
1.2
—
—
—
0
0
55
394
1.41
1.63
1.7
1.3
8.4
28.2
e6/l
0.70
45
314
55
394
1.41
1.63
1.8
1.4
344.8
1036.8
e6/l
0.95
46
327
119
955
1.26
1.63
1.5
1.5
—
—
—
0
0
59
428
1.39
1.63
1.7
1.7
—
—
—
0
0
5
14
3.58
1.61
1.2
1.4
—
—
—
0
0
338
2999
1.15
1.58
1.3
1.2
12.0
13.9
u/ml
0.17
110
1149
14
71
1.98
1.54
1.2
1.1
—
—
—
0
0
5
15
3.34
1.52
1.0
1.5
—
—
—
0
0
7
27
2.60
1.51
4.1
1.3
—
—
—
0
0
39
266
1.48
1.51
2.3
1.9
2976.4
2195.7
u/l
0.11
14
109
431
3901
1.13
1.50
4.7
4.2
1.0
1.0
kg/l
0.12
54
586
16
86
1.87
1.50
1.4
1.3
—
—
—
0
0
18
101
1.79
1.49
1.6
1.2
—
—
—
0
0
23
140
1.65
1.45
1.1
1.1
—
—
—
0
0
18
102
1.77
1.45
1.6
1.2
—
—
—
0
0
6
22
2.73
1.43
1.2
1.3
—
—
—
0
0
17
95
1.80
1.43
1.2
1.1
1.0
1.1
u/l
—
9
49
19
110
1.73
1.43
1.2
1.1
—
—
—
0
0
10
47
2.13
1.33
1.1
1.0
—
—
—
0
0
131
1092
1.21
1.32
1.1
1.2
74.9
142.2
iu/ml
2.73
52
418
36
250
1.45
1.31
1.9
1.8
199.8
203.4
pmol/l
0.07
36
237
6
24
2.50
1.30
1.2
1.3
—
—
—
0
0
9
43
2.10
1.30
1.1
1.1
—
—
—
0
0
21
129
1.63
1.30
1.0
1.0
—
—
—
0
0
10
48
2.09
1.27
1.1
1.1
—
—
—
0
0
8
35
2.29
1.27
1.1
1.0
—
—
—
0
0
9
44
2.05
1.26
1.1
1.1
—
—
—
0
0
38
269
1.42
1.26
1.2
1.2
0.6
0.6
nmol/l
0.39
38
258
63
485
1.31
1.25
2.1
1.8
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
16
92
1.74
1.25
1.1
1.1
—
—
—
0
0
162
1387
1.18
1.23
5.9
5.9
1.4
1.4
mmol/l
0.06
154
1341
10
49
2.05
1.22
1.1
1.1
—
—
—
0
0
51
383
1.34
1.20
2.1
1.7
—
—
—
0
0
17
101
1.69
1.19
1.2
1.5
—
—
—
0
0
33
230
1.44
1.19
1.6
1.3
231.5
312.2
pmol/l
1.55
24
173
54
410
1.33
1.19
1.2
1.1
—
—
—
0
0
10
50
2.00
1.16
1.1
1.1
—
—
—
0
0
31
215
1.45
1.16
1.1
1.1
111.7
115.3
%
0.17
25
194
15
87
1.73
1.15
1.1
1.1
—
—
—
0
0
120
1009
1.20
1.13
1.9
1.9
—
—
—
0
0
19
119
1.60
1.11
1.3
1.4
0.9
1.0
g/l
0.72
19
119
70
558
1.26
1.09
1.4
1.4
38.5
37.8
g/l
0.33
56
463
273
2454
1.13
1.09
26.9
27.4
1.3
1.4
inr
0.27
35
354
5
21
2.38
1.09
1.2
1.0
—
—
—
0
0
8
41
1.95
1.08
1.5
1.3
—
—
—
0
0
9
162
0.55
1.08
1.6
1.5
—
—
—
0
0
10
52
1.93
1.06
1.7
3.2
—
—
—
0
0
10
52
1.93
1.06
1.7
3.2
—
—
—
0
0
115
972
1.19
1.05
9.8
8.0
0.7
0.7
%
0.10
115
964
8
150
0.53
1.03
1.5
1.5
—
—
—
0
0
8
150
0.53
1.03
1.5
1.5
—
—
—
0
0
8
151
0.53
1.03
1.5
1.5
—
—
—
0
0
8
151
0.53
1.03
1.5
1.5
—
—
—
0
0
107
901
1.20
1.02
1.8
1.8
—
—
—
0
0
14
83
1.69
1.01
1.4
1.8
—
—
—
0
0
32
231
1.39
0.99
1.2
1.1
—
—
—
0
0
7
132
0.53
0.99
1.4
1.2
—
—
—
0
0
7
132
0.53
0.99
1.4
1.2
—
—
—
0
0
23
156
1.48
0.98
1.0
1.0
0.2
2.3
u/ml
2.41
11
61
7
134
0.52
0.98
1.4
1.1
—
—
—
0
0
7
134
0.52
0.98
1.4
1.1
—
—
—
0
0
7
134
0.52
0.98
1.4
1.1
—
—
—
0
0
5
23
2.18
0.98
1.2
1.1
34.1
37.7
u/ml
—
5
23
30
215
1.40
0.97
1.6
1.3
130.3
111.6
u/ml
—
10
37
120
1026
1.18
0.97
1.2
1.2
129.6
223.2
u/ml
1.61
106
945
341
3129
1.11
0.96
1.3
1.3
35.4
39.5
iu/ml
0.26
103
985
12
69
1.74
0.96
3.8
1.8
1346.9
134.2
ug/l
0.42
12
61
115
982
1.18
0.95
9.8
7.9
1.3
1.4
%
0.98
115
976
0
32
0.00
0.95
0.0
4.0
—
—
—
0
0
7
37
1.89
0.94
1.1
1.6
—
—
—
0
0
15
93
1.62
0.93
1.1
1.2
—
—
—
0
0
18
117
1.54
0.93
1.4
1.4
0.3
0.3
nmol/l
—
10
96
6
27
2.23
0.93
2.7
2.1
17.2
18.8
umol/l
—
6
27
62
499
1.25
0.93
1.3
1.4
—
—
—
0
0
29
395
0.73
0.91
3.2
3.6
32.3
27.4
mg/l
0.18
21
257
20
135
1.49
0.89
2.2
2.7
—
—
—
0
0
64
521
1.24
0.88
1.5
1.4
0.0
0.0
g/l
0.59
56
476
30
220
1.37
0.87
1.2
1.1
—
—
—
0
0
22
153
1.44
0.85
1.1
1.1
—
—
—
0
0
84
708
1.19
0.83
1.2
1.2
2.5
1.0
u/ml
0.28
11
68
31
231
1.35
0.83
1.6
1.4
48.0
63.6
%
1.25
20
148
49
392
1.26
0.80
2.2
2.1
124.4
131.4
g/l
1.31
38
287
52
420
1.24
0.78
2.3
2.1
87.2
90.3
%
0.35
46
395
11
66
1.67
0.78
1.4
1.2
—
—
—
0
0
11
66
1.67
0.78
1.4
1.2
—
—
—
0
0
33
251
1.32
0.78
1.2
1.2
—
—
—
0
0
19
131
1.45
0.78
1.1
1.0
0.0
0.4
u/ml
—
5
40
53
431
1.24
0.76
1.9
1.9
3.3
4.7
iu/l
0.62
19
142
9
53
1.70
0.75
1.4
1.3
—
—
—
0
0
23
167
1.38
0.73
1.2
1.1
—
—
—
0
0
43
343
1.26
0.73
1.2
1.3
—
—
—
0
0
43
343
1.26
0.73
1.2
1.3
—
—
—
0
0
5
25
2.00
0.72
1.0
1.2
1.5
1.7
umol/24h
—
5
25
5
26
1.93
0.70
1.0
1.1
—
—
—
0
0
5
26
1.93
0.70
1.0
1.1
—
—
—
0
0
10
61
1.64
0.68
1.0
1.0
—
—
—
0
0
45
365
1.24
0.68
1.3
1.2
—
342.2
—
0
9
7
43
1.63
0.67
1.6
2.8
—
—
—
0
0
23
171
1.35
0.65
1.5
1.3
9975.0
197649.9
e6/l
1.85
14
117
7
44
1.59
0.65
2.6
1.8
—
—
—
0
0
28
215
1.31
0.65
1.3
1.3
6.6
7.7
mmol/l
1.99
23
151
70
597
1.18
0.65
7.5
3.8
1.2
1.4
mmol/l
1.88
70
584
44
359
1.23
0.64
1.5
1.5
—
—
—
0
0
5
29
1.73
0.64
2.2
2.2
—
—
—
0
0
37
296
1.25
0.63
3.2
2.8
33.9
34.1
umol/l
0.01
29
254
59
497
1.19
0.63
1.5
1.3
—
—
—
0
0
131
1173
1.12
0.63
2.6
2.4
16.3
25.6
au/ml
—
9
50
61
517
1.19
0.61
1.7
1.6
0.2
6.0
iu/ml
0.49
14
104
43
352
1.23
0.61
1.8
1.7
263.1
306.2
mu/l
0.56
35
320
18
130
1.39
0.61
1.2
1.2
0.5
1.3
u/ml
0.46
13
60
0
20
0.00
0.60
0.0
2.6
—
0.7
—
0
20
18
131
1.38
0.59
1.2
1.5
—
—
—
0
0
53
449
1.19
0.55
1.7
1.5
8769.3
13414.9
e6/l
0.74
35
328
30
241
1.25
0.52
1.2
1.1
—
—
—
0
0
47
397
1.19
0.51
3.2
3.2
0.9
0.8
nmol/l
0.78
33
302
59
513
1.15
0.47
2.1
1.8
—
—
—
0
0
12
85
1.41
0.47
1.1
1.3
—
—
—
0
0
25
200
1.25
0.46
1.2
1.0
8.3
2.3
u/ml
—
9
83
56
486
1.16
0.46
1.5
1.4
0.0
0.0
g/l
0.00
49
442
17
129
1.32
0.45
1.1
1.1
—
—
—
0
0
10
69
1.45
0.44
1.2
1.3
—
—
—
0
0
7
51
1.37
0.44
1.1
1.3
—
—
—
0
0
17
130
1.31
0.44
1.4
1.5
—
182.9
—
0
14
8
56
1.43
0.42
1.5
1.5
—
—
—
0
0
8
56
1.43
0.42
1.1
1.1
—
—
—
0
0
61
538
1.14
0.42
1.8
1.9
—
—
—
0
0
5
33
1.52
0.41
1.4
1.2
—
—
—
0
0
11
80
1.38
0.38
1.4
1.5
—
—
—
0
0
44
382
1.16
0.38
2.2
2.2
186.5
190.9
%
0.10
39
361
41
470
0.87
0.36
1.1
1.2
4.7
6.6
u/ml
—
5
83
54
479
1.13
0.35
1.5
1.4
0.0
0.0
g/l
0.00
49
441
28
236
1.19
0.35
1.3
1.2
308.8
256.2
u/ml
0.46
17
138
54
481
1.13
0.34
1.4
1.5
—
—
—
0
0
20
164
1.22
0.32
1.7
1.6
—
—
—
0
0
160
1691
0.94
0.29
2.5
2.4
6.8
7.5
ug/l
0.21
128
1480
32
366
0.87
0.29
1.1
1.2
62.5
48.1
u/ml
—
5
40
11
86
1.28
0.26
1.2
1.2
—
—
—
0
0
5
73
0.68
0.26
17.0
10.7
0.7
0.6
mmol/l
—
5
67
89
829
1.08
0.26
1.0
1.1
—
—
—
0
0
5
75
0.67
0.25
1.0
1.3
—
—
—
0
0
108
1019
1.06
0.23
1.6
1.6
—
—
—
0
0
52
477
1.09
0.22
2.5
2.3
290.9
97.3
ug/min
0.51
26
288
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.6
—
24.9
—
0
10
151
1579
0.95
0.21
3.4
3.3
2.1
2.1
mmol/l
0.01
135
1288
25
282
0.89
0.20
1.6
1.5
—
—
—
0
0
23
261
0.88
0.20
3.2
4.8
354.9
361.9
umol/l
0.06
16
222
10
123
0.81
0.20
1.0
1.2
—
—
—
0
0
6
50
1.20
0.19
1.5
1.5
17.5
14.7
pmol/l
—
6
40
20
174
1.15
0.19
2.4
3.9
—
—
—
0
0
74
787
0.94
0.19
3.1
2.4
0.6
0.7
%
0.73
74
750
25
222
1.13
0.19
1.4
1.3
—
—
—
0
0
10
81
1.24
0.18
1.1
1.0
—
—
—
0
0
7
58
1.21
0.18
1.0
1.1
1069.3
1765.4
miu/ml
—
7
58
40
367
1.09
0.18
1.1
1.5
0.9
0.8
nmol/l
0.26
27
298
42
387
1.09
0.17
1.1
1.2
—
—
—
0
0
11
91
1.21
0.17
2.6
2.0
—
—
—
0
0
54
504
1.07
0.17
1.3
1.1
—
—
—
0
0
8
73
1.10
0.15
1.1
1.4
—
—
—
0
0
8
73
1.10
0.15
1.1
1.4
—
—
—
0
0
33
359
0.92
0.15
1.3
1.3
67.9
211.8
miu/ml
—
10
157
80
761
1.05
0.15
1.4
1.6
1.5
1.5
g/l
0.05
64
655
10
84
1.19
0.14
2.0
2.5
—
—
—
0
0
65
617
1.06
0.13
1.7
2.3
219.8
797.2
ug/l
1.07
60
579
166
1709
0.97
0.13
1.5
1.7
1.4
1.5
%
1.36
138
1466
21
232
0.90
0.13
1.1
1.0
—
—
—
0
0
24
221
1.09
0.11
1.2
1.2
2.1
6.0
u/ml
—
8
96
13
115
1.13
0.10
1.1
1.2
9.5
11.0
mmol/l
—
7
37
118
1214
0.97
0.10
1.8
1.8
—
—
—
0
0
10
114
0.88
0.09
1.3
1.7
—
—
—
0
0
6
55
1.09
0.09
3.0
1.3
10.0
9.0
ug/l
—
6
55
53
508
1.04
0.08
1.3
1.1
—
—
—
0
0
78
806
0.97
0.08
3.1
2.5
1.2
1.1
%
0.37
78
798
10
88
1.14
0.08
1.3
1.0
—
—
—
0
0
8
90
0.89
0.06
1.1
1.1
—
—
—
0
0
79
769
1.03
0.06
3.4
3.5
24.3
24.3
mmol/l
0.00
73
684
17
158
1.08
0.06
1.8
2.3
895.4
644.2
ml
—
8
105
12
131
0.92
0.05
1.7
1.6
—
—
—
0
0
16
151
1.06
0.03
1.9
1.8
28.6
21.9
u/ml
—
5
41
24
231
1.04
0.02
2.3
2.4
30.8
23.6
mg/l
—
8
55
29
281
1.03
0.02
1.1
1.1
142.8
80.4
iu/ml
—
6
51
16
152
1.05
0.02
1.2
1.1
—
69.6
—
0
7
10
93
1.08
0.02
1.7
1.5
—
—
—
0
0
58
589
0.98
0.02
2.2
1.7
3.5
4.1
mg/l
0.19
44
417
80
793
1.01
0.01
1.5
1.3
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
1.9
—
0
5
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
8
85
0.94
0.00
2.0
1.3
240.2
401.5
u/l
—
8
76
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.6
—
2.4
—
0
5
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_CHOROID_EXALLC – Benign neoplasm: Choroid
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).